tiprankstipranks
Inozyme Pharma (INZY)
NASDAQ:INZY
US Market

Inozyme Pharma (INZY) Technical Analysis

290 Followers

Technical Sentiment

Overall Consensus
Buy
16Bullish
0Neutral
6Bearish
Technical Analysis Consensus
Sell
4Bullish
0Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Inozyme Pharma’s (INZY) Moving Averages Convergence Divergence (MACD) indicator is 0.11, suggesting Inozyme Pharma is a Sell.
Inozyme Pharma’s (INZY) 20-Day exponential moving average is 4.73, while Inozyme Pharma’s (INZY) share price is $5.62, making it a Buy.
Inozyme Pharma’s (INZY) 50-Day exponential moving average is 4.76, while Inozyme Pharma’s (INZY) share price is $5.62, making it a Buy.

Inozyme Pharma (INZY) Pivot Points

Jul 17, 2024, 02:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.81
4.91
5.03
5.13
5.25
5.35
5.47
Fibonacci
4.91
5.00
5.05
5.13
5.22
5.27
5.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inozyme Pharma (INZY) Moving Averages

Jul 17, 2024, 02:46 PM
Period
Simple
Exponential
MA5
4.98Buy
5.07Buy
MA10
4.73Buy
4.86Buy
MA20
4.61Buy
4.73Buy
MA50
4.66Buy
4.76Buy
MA100
5.19Buy
4.86Buy
MA200
4.62Buy
4.69Buy
Inozyme Pharma’s (INZY) 10-Day exponential moving average is 4.86, while Inozyme Pharma’s (INZY) share price is $5.62, making it a Buy.
Inozyme Pharma’s (INZY) 100-Day exponential moving average is 4.86, while Inozyme Pharma’s (INZY) share price is $5.62, making it a Buy.
Inozyme Pharma’s (INZY) stock price is $5.62 and Inozyme Pharma’s (INZY) 50-day simple moving average is 4.66, creating a Buy signal.
Inozyme Pharma’s (INZY) stock price is $5.62 and Inozyme Pharma’s (INZY) 100-day simple moving average is 5.19, creating a Buy signal.
Inozyme Pharma’s (INZY) stock price is $5.62 and Inozyme Pharma’s (INZY) 200-day simple moving average is 4.62, creating a Buy signal.

Inozyme Pharma (INZY) Technical Indicators

Jul 17, 2024, 02:46 PM
Name
Value
Implied Action
RSI (14)
75.25
Sell
STOCH (9,6)
93.93
Sell
STOCHRSI (14)
93.93
Sell
MACD (12,26)
0.11
Sell
ADX (14)
19.35
Buy
Williams %R
-3.80
Sell
CCI (14)
280.11
Sell
ATR (14)
0.22
-
Ultimate Oscillator
70.29
Buy
ROC
21.87
Buy
Inozyme Pharma’s (INZY) Relative Strength Index (RSI) is 75.25, creating a Sell signal.
Inozyme Pharma’s (INZY) Trend Strength Indicator (ADX) is 19.35, creating a Buy signal.
Inozyme Pharma’s (INZY) Commodity Channel Index (CCI) is 280.11, creating a Sell signal.
Inozyme Pharma’s (INZY) Price Rate of Change (ROC) is 21.87, creating a Buy signal.

FAQ

Is INZY a Buy, Hold, or Sell?
Based on INZY’s technical indicators, INZY is a Buy.
    What is INZY’s RSI (14)?
    INZY’s RSI (14) is 75.25, which suggests INZY is a Sell.
      What is INZY’s MACD?
      INZY’s MACD is 0.11, which suggests INZY is a Sell.
        What is INZY’s 5-day moving average?
        INZY’s 5-day moving average is 4.98, which suggests INZY is a Buy.
          What is INZY’s 20-day moving average?
          INZY 20-day moving average is 4.61, which suggests INZY is a Buy.
            What is INZY’s 50-day moving average?
            INZY’s 50-day moving average is 4.66, which suggests INZY is a Buy.
              What is INZY’s 200-day moving average?
              INZY’s 200-day moving average is 4.62, which suggests INZY is a Buy.
                What is INZY’s Williams % R (14)?
                INZY’s Williams % R (14) is -3.80, which suggests INZY is a Sell.
                  What is INZY’s CCI (14)?
                  INZY’s CCI (14) is 280.11, which suggests INZY is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis